SCHEMBL18463527

SCHEMBL18463527

CC1(C)c2ccccc2-c2c(-c3nc(-c4ccccc4)nc(-c4cccc(-c5cccc(-c6ccccc6)c5)c4)n3)cccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.38
ALOX15 P16050 2/20 0.36
TSHR P16473 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
ADORA1 P30542 1/20 0.36
GP6 Q9HCN6 1/20 0.35
PDK2 Q15119 2/20 0.34
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
HPGD P15428 3/20 0.33
LMNA P02545 4/20 0.33
KDM4E B2RXH2 2/20 0.33
GLA P06280 1/20 0.33
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22986989 1.00 L3MBTL1 (0.38) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL22038445 0.99 L3MBTL1 (0.37) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL26937498 0.99 L3MBTL1 (0.37) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL26937484 0.99 GP6 (0.36) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL18463332 0.99 GP6 (0.36) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL18463450 0.96 GP6 (0.34) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL18463349 0.94 L3MBTL1 (0.38) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL20465206 0.94 L3MBTL1 (0.38) L3MBTL1ALOX15TSHRADORA3ADORA2A
SCHEMBL22308831 0.94 MEN1 (0.43) L3MBTL1TSHRADORA2AADORA1PDK2
SCHEMBL17151621 0.93 L3MBTL1 (0.37) L3MBTL1ALOX15TSHRADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328841-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-10-11 EP disclosed
US-20180222872-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed
US-20180222872-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed
WO-2017016630-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2017-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180222872-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES PIEZO1, NES, PIR L3MBTL1 1917/4885ALOX15 3370/4885TSHR 4263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.